TCW Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.4M Buy
50,537
+12,656
+33% +$2.95M 0.09% 128
2025
Q4
$7.84M Buy
+37,881
New +$7.49M 0.06% 143
2025
Q3
Sell
-42,303
Closed -$6.46M 300
2025
Q2
$6.46M Sell
42,303
-30,878
-42% -$4.75M 0.05% 155
2025
Q1
$12.1M Sell
73,181
-38,464
-34% -$6.02M 0.11% 120
2024
Q4
$16.1M Sell
111,645
-6,642
-6% -$1.03M 0.14% 111
2024
Q3
$19.2M Buy
118,287
+3,422
+3% +$545K 0.17% 103
2024
Q2
$16.8M Sell
114,865
-24,929
-18% -$3.71M 0.15% 106
2024
Q1
$22.1M Sell
139,794
-6,431
-4% -$1.02M 0.22% 90
2023
Q4
$22.9M Buy
146,225
+40,658
+39% +$6.23M 0.26% 85
2023
Q3
$16.4M Sell
105,567
-14,587
-12% -$2.41M 0.21% 94
2023
Q2
$19.9M Buy
120,154
+828
+0.7% +$134K 0.22% 87
2023
Q1
$18.5M Sell
119,326
-14,511
-11% -$2.34M 0.24% 88
2022
Q4
$23.6M Sell
133,837
-6,823
-5% -$1.18M 0.34% 72
2022
Q3
$23M Sell
140,660
-46
-0% -$7.78K 0.34% 72
2022
Q2
$25M Buy
140,706
+2,107
+2% +$375K 0.33% 73
2022
Q1
$24.6M Sell
138,599
-6,755
-5% -$1.15M 0.23% 92
2021
Q4
$24.9M Buy
145,354
+118,410
+439% +$19.4M 0.2% 97
2021
Q3
$4.35K Sell
26,944
-93
-0.3% -$15.9K 0.01% 211
2021
Q2
$4.45M Sell
27,037
-18,335
-40% -$3.04M 0.04% 213
2021
Q1
$7.46M Sell
45,372
-309
-0.7% -$50K 0.07% 171
2020
Q4
$7.19M Buy
45,681
+162
+0.4% +$23.9K 0.06% 158
2020
Q3
$6.78M Buy
45,519
+3,595
+9% +$532K 0.07% 150
2020
Q2
$5.9M Buy
41,924
+11,356
+37% +$1.65M 0.07% 151
2020
Q1
$4.01M Sell
30,568
-617
-2% -$87.5K 0.06% 168
2019
Q4
$4.55M Sell
31,185
-100
-0.3% -$13.6K 0.05% 169
2019
Q3
$4.05M Hold
31,285
0.05% 169
2019
Q2
$4.36M Buy
31,285
+1,855
+6% +$257K 0.05% 166
2019
Q1
$4.11M Sell
29,430
-74
-0.3% -$9.91K 0.04% 173
2018
Q4
$3.81M Buy
29,504
+123
+0.4% +$17.2K 0.04% 173
2018
Q3
$4.06M Buy
29,381
+281
+1% +$37.3K 0.03% 184
2018
Q2
$3.53M Sell
29,100
-15,655
-35% -$1.95M 0.03% 186
2018
Q1
$5.74M Sell
44,755
-2,150
-5% -$291K 0.05% 153
2017
Q4
$6.55M Sell
46,905
-2,705
-5% -$377K 0.05% 154
2017
Q3
$6.45M Sell
49,610
-719
-1% -$95.3K 0.05% 161
2017
Q2
$6.66M Buy
50,329
+8,521
+20% +$1.09M 0.06% 162
2017
Q1
$5.21M Sell
41,808
-194,804
-82% -$23.3M 0.04% 165
2016
Q4
$27.3M Sell
236,612
-478,346
-67% -$55.3M 0.21% 92
2016
Q3
$84.5M Sell
714,958
-343,558
-32% -$41.7M 0.64% 62
2016
Q2
$128M Sell
1,058,516
-229,253
-18% -$26M 0.97% 38
2016
Q1
$139M Buy
1,287,769
+8,406
+0.7% +$870K 1.02% 36
2015
Q4
$131M Sell
1,279,363
-100,471
-7% -$10.1M 0.94% 40
2015
Q3
$129M Buy
1,379,834
+21,506
+2% +$2.08M 0.92% 40
2015
Q2
$132M Sell
1,358,328
-654,310
-33% -$65.5M 0.85% 45
2015
Q1
$202M Sell
2,012,638
-329,232
-14% -$33.5M 0.97% 28
2014
Q4
$245M Sell
2,341,870
-415,039
-15% -$43.7M 1.02% 27
2014
Q3
$294M Buy
2,756,909
+35,600
+1% +$3.69M 1.18% 14
2014
Q2
$285M Sell
2,721,309
-46,776
-2% -$4.73M 1.17% 12
2014
Q1
$272M Buy
2,768,085
+118,966
+4% +$11M 1.13% 18
2013
Q4
$243M Buy
2,649,119
+14,182
+0.5% +$1.31M 1.02% 20
2013
Q3
$228M Buy
2,634,937
+562
+0% +$50.4K 1.06% 18
2013
Q2
$226M Buy
+2,634,375
New +$224M 1.12% 17

Other funds holding JNJ

TCW Group's JNJ Position: Q1 2026 in Review

TCW Group increased its Johnson & Johnson (JNJ) stake by 33% in Q1 2026, buying an estimated $2.95M and bringing the position to 50,537 shares worth $12.4M. The position accounts for 0.09% of the portfolio, ranked #128.

TCW Group first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. The position peaked at $294M in Q3 2014. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • TCW Group held 50,537 shares of Johnson & Johnson worth $12.4M as of Q1 2026.
  • TCW Group bought 12,656 Johnson & Johnson shares in Q1 2026, an estimated $2.95M.
  • Johnson & Johnson made up 0.09% of TCW Group's portfolio in Q1 2026, its #128 holding.
  • TCW Group first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • TCW Group's Johnson & Johnson position peaked at $294M in Q3 2014.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on TCW Group's 13F filing for Q1 2026, filed 14 May 2026.